-
Posted: February 20th, 2023, 3:00pm GMT
Condition: Pancreatic Insulinoma
Interventions: Procedure: Endoscopic ultrasound-guided radio frequency ablation; Procedure: Surgery
Sponsor: Azienda Ospedaliera Universitaria Integrata Verona
Recruiting
-
Posted: August 31st, 2022, 2:00pm GMT
Conditions: Insulinoma
Interventions: Procedure: placement of pancreatic duct stents before enucleation surgery; Procedure: Direct enucleation surgery
Sponsors: Peking Union Medical College Hospital; Peking University First Hospital; Xuanwu Hospital, Beijing; First Affiliated Hospital Xi'an Jiaotong University; Ruijin Hospital
Recruiting
-
Posted: October 22nd, 2021, 2:00pm GMT
Condition: Hyperinsulinism
Intervention: Drug: 18F-Fluoro Dopa PET/MRI Imaging
Sponsors: Washington University School of Medicine; St. Louis Children's Hospital
Recruiting
-
Posted: July 28th, 2021, 2:00pm GMT
Conditions: Insulinoma
Interventions: Drug: 68Ga-NOTA-exendin-4
Sponsors: First Affiliated Hospital of Fujian Medical University
Recruiting
-
Posted: June 30th, 2020, 2:00am GMT
Conditions: Hypoglycemia, Reactive; Hypoglycaemia Night; Hypoglycemia Non-Diabetic; Hypoglycemia Unawareness; Insulinoma; Insulinoma; Malignant, Pancreas; Insulin Hypoglycemia; Insulin Resistance; Spontaneous Hypoglycemia; Neuro Endocrine Tumours
Interventions: Device: use of continuous glucose monitoring
Sponsors: Barts & The London NHS Trust
Terminated
-
Posted: August 5th, 2013, 2:00pm GMT
Conditions: Congenital Hyperinsulinism; Beckwith-Wiedemann Syndrome; Insulinoma
Intervention: Drug: 18F-DOPA
Sponsor: Children's Hospital of Philadelphia
Available
-
Posted: April 5th, 2013, 2:00am GMT
Conditions: Gastrinoma; Glucagonoma; Insulinoma; Islet Cell Carcinoma; Pancreatic Polypeptide Tumor; Recurrent Islet Cell Carcinoma; Somatostatinoma
Interventions: Drug: temozolomide; Drug: capecitabine
Sponsors: ECOG-ACRIN Cancer Research Group; National Cancer Institute (NCI)
Active, not recruiting